The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...

The pharmaceutical industry has seen a tremendous surge in the development of weight loss drugs, particularly GLP-1 receptor ...

New-generation anti-obesity drug Wegovy, made by the same company ... with their GP’s approval. The ANSM said in a press release that the use of this type of drug as a treatment for obesity ...

Eli Lilly & Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the U.S., ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...

Related: Employer plans face GLP-1 anti-obesity drug rebate threats Some people who are obese point to the success of the new weight-loss drugs as vindication of the idea that obesity is primarily ...

The agency added that there are “legal restrictions on making copies of FDA-approved drugs” when ... the maker of the anti-obesity drug Wegovy, rose 0.9% in Denmark. Lilly has been investing ...

Newly released data shows that the U.S. may have reached peak obesity in 2020 — and the timing unsurprisingly coincides with ...

More severe side effects can include pancreatitis, vision changes, allergic reactions, fatigue or dizziness, gallstones, ...